Breaking
Monday, June 15, 2026

Regulatory Updates

🇺🇸 FDA Page 19

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 217–228 of 382 articles

Medium impact NewsMay 31, 2026

FDA Device Guidance Agenda: Key Regulatory Updates for 2026

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy

Parkinson's disease · 2 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 30, 2026

MannKind's Pediatric Expansion: A Game Changer for Afrezza Sales

FDA · pediatric diabetes · 4 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 30, 2026

Replimune's Third Attempt at Cancer Drug Approval: Insights from FDA Talks

FDA · cancer · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

Regulatory Actions in May 2026: Key Updates for Pharma

2 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

AI and Brain Organoids Combat Parkinson's and Rare Epilepsy

Parkinson's disease · 3 min

Dr. Sarah Mitchell
Medium impact AnalysisMay 30, 2026

Zydus Therapeutics' Saroglitazar Receives FDA Priority Review

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

PharmTech’s Regulatory Roundup for May 2026: Drug Approvals

3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

Bizengri Receives FDA National Priority Nod for Rare Bile Duct Cancer

FDA · rare bile duct cancer · 2 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

FDA Commissioner Resignation and Its Impact on Drug Approvals

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

States Confront Medical Chatbots Oversight Amid FDA Inaction

FDA · 3 min

Dr. Sarah Mitchell
Medium impact NewsMay 30, 2026

AI Breast Cancer Risk Prediction Tool Gains FDA Approval

FDA · oncology · 3 min

Dr. Sarah Mitchell